e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Development and external validation of 1- and 2-year mortality prediction models in cystic fibrosis
Sanja Stanojevic, Jenna Sykes, Anne L. Stephenson, Shawn D. Aaron, George A. Whitmore
Source:
Eur Respir J, 54 (3) 1900224; 10.1183/13993003.00224-2019
Journal Issue:
September
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sanja Stanojevic, Jenna Sykes, Anne L. Stephenson, Shawn D. Aaron, George A. Whitmore. Development and external validation of 1- and 2-year mortality prediction models in cystic fibrosis. Eur Respir J, 54 (3) 1900224; 10.1183/13993003.00224-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
The CF-ABLE score: A 2-year evaluation of a 4-year prognostic tool
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015
External validation of the French predictive model to estimate PAH survival: A REVEAL analysis
Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries
Year: 2012
Validated the power of terminal status criteria in the prediction of 1-year mortality in patiens with COPD
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020
External validation of the REVEAL risk score calculator for PAH survival: A French pulmonary hypertension network analysis
Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries
Year: 2012
Design and assessment of an automated prediction model for 30-day re-hospitalization after a COPD exacerbation using genetic algorithms
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019
Extent of fibrosis by high-resolution computed tomography does not improve prediction of mortality in idiopathic pulmonary fibrosis when added to a simple clinical prediction model
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Assessment of NuvoAir platform use on clinical outcomes in adults with cystic fibrosis: a first Italian experience
Source: Virtual Congress 2021 – Cystic fibrosis
Year: 2021
Early diagnosis from newborn screening maximises survival in severe cystic fibrosis
Source: ERJ Open Res, 4 (2) 00109-2017; 10.1183/23120541.00109-2017
Year: 2018
One-year follow-up for lung function and functional capacity in cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 183s
Year: 2005
Risk prediction and end-points in idiopathic pulmonary fibrosis: one step at a time
Source: Eur Respir J 2014; 43: 1237-1239
Year: 2014
Factors predicting mortality in cystic fibrosis where lung transplantation can not be performed
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012
Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis
Source: Eur Respir J 2015; 45: 1374-1381
Year: 2015
GAP scoring system in IPF patients treated with antifibrotics: prognostic performance and 1- to 3- years mortality: a retrospective study
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Idiopathic pulmonary fibrosis: independent physiologic variables in the prediction of survival
Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis
Year: 2007
Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
Source: Eur Respir J 2012; 40: 101-109
Year: 2012
A contemporary survival analysis of individuals with cystic fibrosis: a cohort study
Source: Eur Respir J 2015; 45: 670-679
Year: 2015
Use of NIV in cystic fibrosis: 10-year experience of a large adult CF centre
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients
Source: Eur Respir J 2001; 18: 306-315
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept